Nižić Nodilo, L.; Ugrina, I.; Špoljarić, D.; Amidžić Klarić, D.; Jakobušić Brala, C.; Perkušić, M.; Pepić, I.; Lovrić, J.; Saršon, V.; Safundžić Kučuk, M.;
et al. A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies. Pharmaceutics 2021, 13, 795.
https://doi.org/10.3390/pharmaceutics13060795
AMA Style
Nižić Nodilo L, Ugrina I, Špoljarić D, Amidžić Klarić D, Jakobušić Brala C, Perkušić M, Pepić I, Lovrić J, Saršon V, Safundžić Kučuk M,
et al. A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies. Pharmaceutics. 2021; 13(6):795.
https://doi.org/10.3390/pharmaceutics13060795
Chicago/Turabian Style
Nižić Nodilo, Laura, Ivo Ugrina, Drago Špoljarić, Daniela Amidžić Klarić, Cvijeta Jakobušić Brala, Mirna Perkušić, Ivan Pepić, Jasmina Lovrić, Vesna Saršon, Maša Safundžić Kučuk,
and et al. 2021. "A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies" Pharmaceutics 13, no. 6: 795.
https://doi.org/10.3390/pharmaceutics13060795
APA Style
Nižić Nodilo, L., Ugrina, I., Špoljarić, D., Amidžić Klarić, D., Jakobušić Brala, C., Perkušić, M., Pepić, I., Lovrić, J., Saršon, V., Safundžić Kučuk, M., Zadravec, D., Kalogjera, L., & Hafner, A.
(2021). A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies. Pharmaceutics, 13(6), 795.
https://doi.org/10.3390/pharmaceutics13060795